PROXIDRUGS project leader Christian Münch organizes EMBO-FEBS Susan Lindquist School on Proteostasis
From Oct 3rd to Oct 6th 2023 the EMBO-FEBS Lecture Course will give a comprehensive overview of past and current work on proteostasis to...
top of page
Aug 24, 2023
PROXIDRUGS takes part in the ClusterTalk of the Technologieland Hessen
You would like to learn - which objectives the Hessian clusters and networks pursue? - what activities there are in the...
Aug 23, 2023
ProxiDETECT partner Revvity launches new kit
The associated PROXIDRUGS partner Revvity launched a detection kit for quantifying the expression level of RNA-binding motif protein 39...
Jul 9, 2023
PROXIDRUGS Workshop on conceptualization of the 2nd funding period
Today the PROXIDRUGS consortium met to get started with the conceptualization of the second funding period. It was a fruitful day full of...
Jun 19, 2023
New partners welcome – strategic expansion of PROXIDRUGS cluster in next funding round
Join a continuously expanding research-driven partnership focused on innovative therapies for human diseases. Funded within the first...
Jun 5, 2023
Jochen Hückmann Foundation Guest Professorship for Judith Frydman
The PROXIDRUGS community welcomes Judith Frydman (Stanford University, USA) at Goethe University. Judith Frydman was awarded with the...
May 9, 2023
Launch of Revvity – a PROXIDRUGS partner
Revvity, Inc., a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives...
Jan 24, 2023
Ivan Đikić receives Louis-Jeantet Prize for Medicine
Together with Brenda Schulman, Director at the Max Planck Institute of Biochemistry in Martinsried, PROXIDRUGS speaker Ivan Đikić will...
Nov 16, 2022
PROXIDRUGS project leaders Ivan Đikić and Stefan Knapp are Highly Cited Researchers 2022
The list of Highly Cited Researchers identifies pioneers in their respective fields who repeatedly demonstrated significant and broad...
Oct 19, 2022
Commentary: Localization matters!
In the latest issue of Cell Chemical Biology, PROXIDRUGS scientists Varun Shah and Ivan Đikić comment on an article published by Simpson...
bottom of page